Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
Gilead Sciences(GILD) stock is priced at $166.78, giving the company a market capitalization of 206.87B. It carries a P/E multiple of -53.67 and pays a dividend yield of 1.92%.
During the trading session on 2026-11-19, Gilead Sciences(GILD) shares reached a daily high of $169.16 and a low of $166.14. At a current price of $166.78, the stock is +0.4% higher than the low and still -1.4% under the high.
Trading activity shows a volume of 684.16K, compared to an average daily volume of 5.51M.
The stock's 52-week range extends from a low of $116.88 to a high of $176.58.
The stock's 52-week range extends from a low of $116.88 to a high of $176.58.
GILD News
Gilead Sciences (GILD) just put its HIV prevention portfolio in the spotlight after new PURPOSE 5 trial data showed that twice-yearly lenacapavir kept more peop...
...
Gilead Sciences (GILD Quick QuoteGILD - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some...
Analyst ratings
76%
of 29 ratingsMore GILD News
Gilead Sciences Inc. (NASDAQ:GILD) said Monday it signed royalty-free voluntary licensing agreements with three generic drugmakers to support potential future a...
Artificial intelligence (AI) stocks continue dominating headlines on Wall Street. That probably won't change anytime soon. But investors shouldn't be so distrac...
Gilead (GILD) Sciences announced that it has signed royalty-free voluntary licensing agreements with three generic manufacturers to support potential future acc...
It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...
Gilead Sciences (NasdaqGS:GILD) received FDA approval for Bixlenvo, a bictegravir and lenacapavir regimen for HIV treatment. The firm has a Biologics License A...
Gilead Sciences ((GILD)) has held its Q3 earnings call. Read on for the main highlights of the call. Gilead Sciences delivered a strongly positive third-quarte...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.